George Gourzoulidis

18PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGeriatrics and gerontologyInfant and child healthEconometric and statistical methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 12, 2026
Cost-effectiveness analysis of liposomal irinotecan in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas in Greece.

|Oct 28, 2025
Real-World Prevalence, Treatment Patterns, and Economic Impact of EGFR- and ALK-Targeted Therapies in Non-Small Cell Lung Cancer: A Nationwide Analysis from Greece.

George Gourzoulidis, Catherine Kastanioti, George Mavridoglou

|Aug 22, 2025
Disease Burden and Unmet Medical Needs in Patients with Ulcerative Colitis in Greece: A Cross-Sectional Patient Survey.

George Gourzoulidis, Vasiliki-Rafaela Vakouftsi, George Mavridoglou

|Jun 03, 2025
Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine (PCV20) to prevent pneumococcal disease in the Greek pediatric population.

|Mar 26, 2025
Does Real-World Evidence of the Economic Burden of Lung Cancer in Greece Exist? A Systematic Review of the Literature.

George Gourzoulidis, Catherine Kastanioti, George Mavridoglou

|Jan 24, 2025
Retrospective, Non-Interventional, Multicenter Study on the Effectiveness and Safety of Intravesical Bacillus Calmette-Guerin in Patients with Non-Muscle-Invasive Bladder Cancer: Real-World Experience from Six Hospital Centers in Greece.

Panagiotis Angelopoulos, Titos Markopoulos, Lazaros Lazarou

Pageof 3

Frequent Collaborators

4 joint publications

George Mavridoglou

2 joint publications

Leonidas G Ioannou

2 joint publications

Petros C Dinas

2 joint publications

Sean R Notley